While Fools should generally take the opinion of Wall Street with a grain of salt, it's not a bad idea to take a closer look at particularly stock-shaking analyst upgrades and downgrades -- just in case their reasoning behind the call makes sense.
What: Shares of Walgreen Company (NASDAQ:WBA) slipped about 1% today after Cantor Fitzgerald downgraded the drugstore chain from hold to sell.
So what: Along with the downgrade, analyst Ajay Jain planted a price target of $50 on the stock, representing about 25% worth of downside to yesterday's close. While momentum traders might be attracted to the stock's strength over the past year, Jain's call could reflect a growing sense on Wall Street that Walgreen's run is overdone.
Now what: According to Cantor, Walgreen's risk/reward trade-off is pretty unattractive at this point. "[W]ith WAG's share price up by close to 17% following the 1Q earnings release on 12/20, we can't justify a HOLD rating without a meaningful increase in our price target," Jain said. "WAG also discounts significant earnings upside from Alliance Boots even as the core earnings growth remains in the low-single digits. Finally, based on what we view as some questionable earnings quality recently, we think it's appropriate to highlight this issue." When you couple those seemingly reasonable concerns with Walgreen's 20-plus P/E, it's tough to disagree with Cantor's bearishness.
More reliable ways to build wealth
One of the dirty secrets that few finance professionals will openly admit is the fact that dividend stocks as a group handily outperform their non-dividend paying brethren. The reasons for this are too numerous to list here, but you can rest assured that it's true. However, knowing this is only half the battle. The other half is identifying which dividend stocks in particular are the best. With this in mind, our top analysts put together a free list of nine high-yielding stocks that should be in every income investor's portfolio. To learn the identity of these stocks instantly and for free, all you have to do is click here now.
Brian Pacampara has no position in any stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.